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Abstract
Transcriptional regulatory networks are fundamental to how microbes alter gene expression in response to environmental
stimuli, thereby playing a critical role in bacterial pathogenesis. However, understanding how bacterial transcriptional
regulatory networks function during host-pathogen interaction is limited. Recent studies in group A Streptococcus (GAS)
suggested that the transcriptional regulator catabolite control protein A (CcpA) influences many of the same genes as the
control of virulence (CovRS) two-component gene regulatory system. To provide new information about the CcpA and
CovRS networks, we compared the CcpA and CovR transcriptomes in a serotype M1 GAS strain. The transcript levels of
several of the same genes encoding virulence factors and proteins involved in basic metabolic processes were affected in
both DccpA and DcovR isogenic mutant strains. Recombinant CcpA and CovR bound with high-affinity to the promoter
regions of several co-regulated genes, including those encoding proteins involved in carbohydrate and amino acid
metabolism. Compared to the wild-type parental strain, DccpA and DcovRDccpA isogenic mutant strains were significantly
less virulent in a mouse myositis model. Inactivation of CcpA and CovR alone and in combination led to significant
alterations in the transcript levels of several key GAS virulence factor encoding genes during infection. Importantly, the
transcript level alterations in the DccpA and DcovRDccpA isogenic mutant strains observed during infection were distinct
from those occurring during growth in laboratory medium. These data provide new knowledge regarding the molecular
mechanisms by which pathogenic bacteria respond to environmental signals to regulate virulence factor production and
basic metabolic processes during infection.
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Introduction
It has long been recognized that the gene expression profile of
bacterial pathogens differs significantly during infection compared
to the laboratory environment [1]. For example, a recent study of
Listeria monocytogenes found that more than 1,000 genes were
differentially expressed when comparing bacteria grown in a
standard laboratory medium with the same bacteria recovered
from mouse intestine [2]. Genes encoding bacterial virulence
factors are often upregulated during infection, but the molecular
mechanisms governing virulence gene expression in the host are
only beginning to be understood [3,4]. Specifically, there is a
dearth of information available regarding how transcriptional
regulatory networks function in response to host environmental
stimuli to determine virulence factor production [5].
Group A Streptococcus (GAS) causes infections in humans ranging
from uncomplicated pharyngeal and skin infections to necrotizing
fasciitis and toxic shock-like syndrome [6]. The ability of GAS to
cause infection in diverse human niches indicates that GAS has
evolved precise mechanisms to alter gene expression depending on
the distinct challenges posed by particular disease sites [7,8,9]. Unlike
some other pathogenic bacteria, GAS does not appear to regulate
virulence factor production by alternative sigma factors that can
associate with core RNA polymerase [10,11]. Thus, gene expression
in GAS is heavily dependent on transcriptional regulatory networks
[12]. GAS encodes two main types of regulatory proteins, namely
stand-alone regulators and two-component gene regulatory systems
(TCS) [12,13]. The interaction of stand-alone regulators with DNA
changes with alterations in intracellular conditions, such as the
presence of an inducing substrate [12]. In contrast, TCS typically
consist of a membrane-embedded sensor kinase that controls the
phosphorylation state of a cognate cytoplasmic response regulator in
response to environmental stimuli [14]. The phosphorylation state of
the regulator influences its DNA binding activity thereby affecting
gene expression [15]. Although interaction between TCS and stand-
alone regulators is clearly critical to bacterial pathogenesis,
information regarding how independent bacterial regulators coordi-
nate gene expression during infection is lacking.
PLoS Pathogens | www.plospathogens.org 1 March 2010 | Volume 6 | Issue 3 | e1000817The best studied GAS transcription factor is the control of
virulence regulator (CovR), also known as CsrR for capsule
synthesis regulator [7,16,17,18,19]. CovR is the response regulator
of the CovRS TCS [7]. Studies done over the past decade have
revealed several intriguing aspects of the CovRS TCS. First, in
contrast to most TCS regulators, CovR mainly serves to negatively
affect gene expression, including repressing numerous genes
encoding key virulence factors [7,19,20]. Thus, GAS strains in
which CovR has been genetically inactivated are hypervirulent for
mice [17,20,21,22]. Second, CovR appears to be able to function
independently of CovS as GAS strains with isogenic CovR or
CovS mutations have different phenotypes [16,23]. Third,
phosphorylation of CovR generally leads to an increase in affinity
for target DNA in vitro although the degree to which phosphor-
ylation increases CovR binding affinity differs for various
promoters [24,25]. Finally, spontaneous mutations in covR or covS
have been identified in strains from animals with experimental
GAS infections and humans with invasive infections indicating
that mutations in covRS provide an advantage in select in vivo
environments [21,26,27,28].
Although most CovRS-related research has focused on virulence
factor regulation, the CovR regulon also includes many genes
involved in carbohydrate catabolism and nitrogen utilization
[20,29]. Inasmuch as CovR regulates genes involved in virulence
and basic metabolic processes, CovR appears to have a similar
transcriptional profile to catabolite control protein A (CcpA)
[30,31]. CcpA is a stand-alone, global regulatory protein critical
to selective carbon source utilization and nitrogen metabolism that
has recently been shown to contribute to virulence in GAS and
other Gram-positive pathogens [30,31,32,33,34,35]. Studies in
Bacillus species and other non-pathogenic Gram-positive bacteria
have found that the binding of CcpA to DNA catabolite response
element (cre) sites is significantly enhanced by interaction of CcpA
with histidine containing phosphoprotein (HPr) phosphorylated at
serine residue 46 (HPr-Ser46-P) [36,37]. The HPr phosphorylation
state is determined by the action of HPr kinase/phosphorylase
(HPrK/P), a bifunctional enzyme whose activity, in turn, is affected
by the intracellular concentration of carbohydrate catabolism pro-
ducts [38]. Orthologues of CcpA, HPr, and HPrK/P from Bacillus
species are present in all fully sequenced Gram-positive pathogens.
However, definitive evidence that the CcpA-(HPr-Ser46-P)-HPrK/
P axis functions in a similar fashion in pathogenic Gram-positive
organisms to that observed in Bacillus species is lacking, and there
are limited data available regarding how CcpA influences gene
expression during infection [39].
Analysis of the CcpA transcriptome in GAS led to the
understanding that many genes influenced by CcpA also are part
of the CovR transcriptome [30,31]. Moreover, bioinformatic
analysis suggests that CcpA and CovR DNA binding sites can be
proximally located [30,31]. Similarly, studies of CcpA and CovR
orthologues in Staphylococcus aureus (in which the CovR orthologue
is known as ArlR for autolysis related locus) and Streptococcus mutans
have suggested significant overlap in genes regulated by these two
proteins in non-GAS pathogenic bacteria [34,40,41,42]. There-
fore, we designed studies to test the hypothesis that the CcpA and
CovRS systems co-regulate expression of a diverse array of GAS
genes. Our results indicate that CcpA and CovR combine to shape
the expression profile of GAS virulence factor-encoding genes and
basic metabolic genes during infection. These data provide new
insights into how transcriptional regulatory networks contribute to
bacterial gene expression in the host environment and extend
understanding of the close links between virulence and basic
metabolic processes [43].
Results
The influence of CcpA on virulence factor production is
dependent on GAS strain CovRS status
Pharyngeal GAS isolates usually have an intact (wild-type)
CovRS system whereas GAS isolates recovered from invasive
infections may have inactivating mutations in either CovR or
CovS [21,26,27]. The two previous genome-wide studies on the
effect of CcpA inactivation in GAS have both used the invasive
clinical isolate serotype M1 strain MGAS5005, which encodes a
truncated, functionally inactive CovS protein [16,26,30,31]. To
test the hypothesis that the effects of CcpA are dependent on
CovRS status, we used non-polar insertional mutagenesis to create
a DccpA isogenic mutant (strain 2221DccpA, Figure S1, Table 1)
from the wild-type parental strain MGAS2221, a fully-sequenced
serotype M1 strain that contains an intact CovRS TCS (Southern
blot shown in Figure S1B) [26]. We genetically complemented the
2221DccpA isogenic mutant strain using a CcpA-encoding plasmid
that replicates in GAS to make strain comp2221DccpA. The
growth characteristic of the three strains in a standard laboratory
medium (Todd-Hewitt broth with yeast extract, THY) were
indistinguishable (Figure S2).
We next determined the transcript level of the gene encoding
streptococcal pyrogenic exotoxin B (SpeB) in the CovRS wild-type
strains MGAS2221, 2221DccpA, and comp2221DccpA and in the
CovS mutated strains MGAS5005, 5005DccpA, and
comp5005DccpA. speB encodes a broad-spectrum, extracellular
cysteine protease that is a key GAS virulence factor [44]. We
analyzed speB because it is negatively regulated by CovR in
serotype M1 strains, and a putative cre site is located approximately
100 bps into the speB open reading frame suggesting it could be
directly regulated by CcpA [20] (Figure S3). During growth in
THY, there was no significant difference in speB transcript level
between strain MGAS5005 and its CcpA inactivated isogenic
mutant strain (Figure 1A). In contrast, speB transcript level was
significantly increased at the stationary phase of growth in strains
MGAS2221 and comp2221DccpA compared to strain 2221DccpA
(Figure 1A). Western immunoblot analysis (Figure 1B) and casein
hydrolysis assays (Figure 1C) demonstrated that the observed
Author Summary
Group A Streptococcus (GAS) causes diverse infections in
humans ranging from pharyngitis (strep throat) to
necrotizing fasciitis (the flesh-eating disease). It is well
known that GAS secretes a broad array of virulence factors
that are critical to its ability to cause human infections, but
how GAS coordinates virulence factor production during
infection is poorly understood. We discovered that two
GAS proteins, catabolite control protein A (CcpA) and
control of virulence regulator (CovR), regulate production
of many of the same virulence factor encoding genes,
indicating that GAS uses these two regulatory proteins to
modulate virulence factor production in response to
environmental stimuli. We determined that CcpA and
CovR are able to bind to DNA from co-regulated genes,
indicating that the proteins control gene expression by
directly interacting with DNA. Using a mouse model of
muscle infection, we found that CcpA and CovR, alone and
in combination, are critical to the ability of GAS to regulate
expression of virulence factor encoding genes during
infection. These findings increase understanding regarding
the regulatory mechanisms critical to the ability of
bacterial pathogens to cause infection.
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reactive SpeB in culture supernatants and in functional SpeB
activity. These data demonstrate that, under the conditions tested,
CcpA positively contributed to speB expression in the presence of a
functional CovRS TCS but did not affect speB expression when
CovS was inactive.
To determine if CovRS status affected the influence of CcpA on
GAS virulence factors other than SpeB, we performed similar
experiments to those described for SpeB using streptolysin O (Slo),
an actively secreted cytotoxin [45] and Streptococcus pyogenes cell
envelope proteinase (SpyCEP), an IL-8 degrading enzyme [46].
Putative cre sites are located in the slo promoter, which is co-
transcribed with the nga gene (herein labeled nga/slo cre), and in the
early spyCEP intragenic region (Figure S3), and CovR negatively
regulates nga/slo and spyCEP in serotype M1 strains [16,20]. As
observed for SpeB, CcpA influenced the level of slo and spyCEP
transcript in strain MGAS2221 but not strain MGAS5005
(Figure 1D, 1E). In contrast to our findings with speB, slo, and
spyCEP, the transcript level of sagA, which encodes the first gene of
the operon encoding the potent cytolysin streptolysin S (SLS), was
significantly increased by CcpA inactivation in strain MGAS2221
as well as in strain MGAS5005 (Figure 1F). We and others have
previously demonstrated binding of CcpA to the sagA promoter
[30,31]. Taken together, we conclude that the effect of CcpA on
the expression of several key GAS virulence encoding genes varies
depending on the functional CovRS status of the parental GAS
strain.
Recombinant CcpA-(HPr-Ser46-P) binds to DNA from
multiple GAS CovR-regulated virulence factor encoding
genes
We next tested the hypothesis that CcpA specifically binds to
the putative speB, nga/slo, and spyCEP cre sites. For these studies,
recombinant GAS CcpA, HPr, and HPrK/P were overexpressed
and purified, and HPrK/P was used to produce HPr-Ser46-P as
described in Materials and Methods (Figure 2). CcpA alone bound
with high affinity to the speB cre site with a Kd of 100 nM
(Figure 3A). As expected for a CcpA DNA binding site, the
addition of HPr-Ser46-P significantly increased the affinity of
CcpA for the speB cre site to a Kd of 5 nM (Figure 3A). Conversely,
analysis of CcpA-(HPr-Ser46-P) binding to DNA from the ftsX
promoter, a gene whose transcript level was not influenced by
CcpA inactivation (e.g. a negative control), produced a non-
specific DNA binding pattern (Figure 3B). Similarly, recombinant
CcpA and the CcpA-(HPr-Ser46-P) complex also bound with high
affinity to the nga/slo (Kd of 674 nM and 42 nM, respectively) and
spyCEP (Kd of 257 nM and 33 nM, respectively) cre sites (Figure 3C
and 3D). Together with previously published data indicating
binding of CcpA to the sagA promoter, these data demonstrate that
recombinant CcpA and the CcpA-(HPr-Ser46-P) complex bind
with high affinity to cre site DNA from multiple virulence factor
encoding genes that are directly regulated by CovR.
CovR inactivation does not influence CcpA transcript
levels under laboratory conditions
One potential mechanism by which the CovRS status of GAS
could affect CcpA function is for CovR to regulate CcpA
expression. The consensus GAS CovR binding sequence is
ATTARA, where R = A or G [7]. There is one ATTARA motif
in the vicinity of the CcpA promoter. We tested whether CovR
influenced CcpA transcript level by determining ccpA transcript
level in strain 2221DcovR [16]. During growth in THY there was
no significant difference in ccpA transcript level between strains
MGAS2221, 2221DcovR, or MGAS5005 (the covS mutant strain)
(Figure S4). There are no putative cre sites in the CovR promoter
region. Thus, not surprisingly, there was no significant difference
in covR transcript level between strains MGAS2221 and 2221DccpA
or strains MGAS5005 and 5005DccpA (Figure S4). These data
Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Description Genotype Reference
MGAS2221 Pharyngitis clinical isolate, serotype M1 Wild-type for covRS [26]
2221DccpA DccpA strain MGAS2221 ccpA::spc This study
comp2221DccpA DccpA strain with CcpA complementation vector DccpA/ccpA+, Spc
r Cm
r This study
2221DcovR DcovR strain MGAS2221 covR::kana [16]
2221DcovRDccpA DcovRDccpA strain 2221DcovR ccpA::spc This study
MGAS5005 Invasive clinical isolate, serotype M1 DcovS nt80 [67]
5005DccpA DcovSDccpA strain MGAS5005 ccpA::spc [30]
comp5005DccpA DcovSDccpA strain with CcpA complementation vector DccpA/ccpA+, Spc
r Cm
r [30]
BL21-CcpA E. coli BL21 producing recombinant GAS CcpA BL21 pET-His2-CcpA Amp
r [30]
BL21-CovR E. coli BL21 producing recombinant GAS CovR BL21 pTXB1-CovR Amp
r This study
BL21-HPr E. coli BL21 producing recombinant GAS HPr BL21 pET-His2-HPr Amp
r This study
BL21-HPrK/P E. coli BL21 producing recombinant GAS HPr kinase/phosphorylase BL 21 pET21a-HPrK/P Amp
r This study
pSL60-1 Vector containing aad9 gene Spc
r [68]
pDC123 Chloramphenicol resistance vector Cm
r [63]
pDCccpA pDC123 with CcpA Cm
r [30]
pET-His2-CcpA pET-His2 plasmid with GAS CcpA gene ccpA
+ Amp
r [30]
pTXB1-CovR pTXB1 plasmid with GAS CovR gene covR
+ Amp
r This study
pET-His2-HPr pET-His2 plasmid with GAS HPr gene hpr
+ Amp
r This study
pET21a-HPrK/P pET21a plasmid with GAS HPrK/P gene hprK/P
+ Amp
r This study
doi:10.1371/journal.ppat.1000817.t001
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expression of several of the same key GAS virulence factors,
CovR and CcpA do not influence the transcript level of the other
regulator under the conditions studied.
Identification of significant overlap between the CcpA
and CovR transcriptomes
To better understand the relationship between CcpA and the
CovRS TCS, we created a CcpA/CovR double mutant strain by
genetically inactivating ccpA in strain 2221DcovR, resulting in strain
2221DcovRDccpA (Table 1, Figure S1). There was no significant
difference in the doubling time or final density of organisms grown
in THY between strain 2221DcovRDccpA and strains MGAS2221,
2221DccpA, and 2221DcovR (Figure S2C, Table S1). Although
previous experiments suggested that CcpA and CovR influence
expression of many of the same GAS genes, the CcpA and CovR
transcriptomes have not been directly compared [20,29,30,31].
Therefore, we next tested the hypothesis that inactivation of CcpA
and CovR have similar effects on the GAS transcriptome by
performing expression microarray analysis of strains MGAS2221,
2221DccpA, 2221DcovR, and 2221DcovRDccpA during the mid-
exponential and stationary phases of growth in THY (see Figure
S2C for RNA isolation points and Figure S5 for principal
component analyses of the microarray data). Quadruplicate
replicates were performed for each strain at each time point. At
both the mid-exponential and stationary growth points, the
percent of total ORFs with a significant difference in transcript
levels compared to the wild-type strain was approximately 10% for
strain 2221DccpA, 15% for strain 2221DcovR, and 20% for strain
2221DcovRDccpA (Tables S2, S3 and S4).
We discovered significant overlap in the CcpA and CovR
transcriptomes, primarily in genes encoding proteins known to be
or putatively involved in virulence and in the transport and
metabolism of carbohydrates and amino acids (Table 2). Genes
encoding proteins known to be or putatively involved in virulence
that were affected by both CcpA and CovR included speB, spyCEP,
endoS, and the operons encoding SLS and Slo (Figure 4A). EndoS
(endoglycosidase S) cleaves a glycan side chain from human
immunoglobulin G [47]. The effects of CcpA and CovR on sagA,
slo, spyCEP, and speB transcript level were confirmed by QRT-
PCR (Figure S6). A casein hydrolysis assay confirmed that strain-
to-strain differences in speB transcript levels resulted in altered
functional SpeB activity (Figure S6E). All putative virulence factor
genes that were affected by CcpA inactivation were also affected
by CovR inactivation. However, the CovR transcriptome included
several GAS virulence factors not influenced by CcpA such as the
genes encoding streptokinase and the immunoglobulin cleaving
protease Mac-1/IdeS (Tables S2 and S3).
In addition to finding that CovR and CcpA influenced
expression of several of the same virulence factor genes, we also
observed alterations in the transcript levels of many of the same
Figure 1. Influence of CcpA on GAS virulence factors is dependent on strain CovRS status. TaqMan real-time QRT-PCR for (A) speB, (D) slo,
(E) spyCEP, and (F) sagA was performed for cells grown to indicated growth phase (mid-exp = mid-exponential). From left to right bars represent:
MGAS2221 (CovRS wild-type, green); 2221DccpA (blue); comp2221DccpA (red); MGAS5005 (CovS mutant, yellow); 5005DccpA (purple); and
5005compDccpA (black). (B) Western immunoblot for SpeB in culture supernatants of indicated strains grown overnight in THY. The multiple bands
observed represent zymogen (40 kb), intermediate, and mature (28 kb) SpeB forms reacting with anti-SpeB antibody [65]. (C) Casein hydrolysis of
indicated strains as a measure of SpeB enzymatic activity. For all panels except (B) data graphed are mean +/2 standard deviation of four biological
replicates done on two separate occasions (i.e. eight samples). * indicates P,0.05 compared to CcpA inactivated strain as determined by ANOVA
followed by Tukey’s post-hoc test. speB, streptococcal pyrogenic exotoxin B; slo, streptolysin O; spyCEP, Streptococcus pyogenes cell envelope
proteinase; sagA, streptolysin S.
doi:10.1371/journal.ppat.1000817.g001
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2221DcovRDccpA strains compared to strain MGAS2221 (Table 2,
Figure 4B). These included operons known to be or putatively
involved in carbohydrate metabolism and operons encoding
proteins in the arginine deiminase and histidine degradation
pathways. For metabolic operons, CcpA inactivation tended to
result in more significant alteration in transcript levels compared
to CovR inactivation (e.g. the differences in the transcript of arcA,
the first gene in the arginine deminase operon, were ,20-fold
between wild-type and strain 2221DccpA vs. ,3-fold between wild-
type and strain 2221DcovR, Figure 4B). Moreover, CcpA
inactivation affected several metabolic operons that were not
affected by CovR inactivation (e.g. the putative mannose/fructose
transport system operon). Taken together, we conclude that under
laboratory conditions CcpA and CovR influence expression of
many of the same genes with CovR having a greater impact on
virulence gene expression whereas CcpA has a greater influence
on the expression of genes involved in basic metabolic processes.
Recombinant GAS CovR and CcpA-(HPr-Ser46-P) bind
with high affinity to promoter DNA of the same
metabolic genes
The significant overlap between the CovR and CcpA
transcriptomes led us to hypothesize that these two proteins bind
to the promoter DNA of several of the same genes. Recombinant
CovR was overexpressed, purified, and phosphorylated as
described in Materials and Methods (Figure 2). This purified
CovR lacks non-native residues, can be readily concentrated, and
remains soluble at high concentrations. We used fluorescence
polarization to study protein-DNA interaction because this
method is equilibrium-based and done in solution, thereby
approximating the in vivo environment (for details on fluorescence
polarization see the Materials and Methods section) [48].
Fluorescence polarization has not been previously used to study
CovR-DNA interaction. Therefore, we first tested the binding of
recombinant CovR to the hasA promoter for which CovR-DNA
interaction has been well characterized [18,25,49]. Recombinant
CovR bound to the hasA promoter DNA with an approximately 4-
fold increase in affinity when CovR was phosphorylated (Kd
decreased from 2200 nM to 640 nM, Figure 5A), which is
consistent with previous reports regarding the effects of phosphor-
ylation on CovR-hasA promoter binding [18,25]. Analysis of
recombinant CovR with labeled DNA from the promoter region
of the non-CovR regulated gene typA (i.e. a negative control)
produced low polarization changes and linear binding consistent
with low affinity, non-specific DNA binding (Figure 5B). These
data indicated that we could reliably use fluorescence polarization
to investigate CovR-DNA binding.
In terms of genes involved in basic metabolic processes, the
transcriptome data demonstrated altered transcript levels of arcA,
which encodes a protein involved in arginine utilization, and amyA,
which encodes an actively secreted carbohydrate-degrading
protein, in strains 2221DccpA and 2221DcovR compared to wild-
type (Figure 4B). Thus, we next tested the hypothesis that
recombinant CovR and recombinant CcpA-(HPr-Ser46-P) bind
with high affinity to DNA from the arcA and amyA promoters.
Recombinant CovR bound specifically and with reasonably high
affinity to the promoter regions of the arcA (Kd of 637 nM and
230 nM for unphosphorylated and phosphorylated CovR respec-
tively, Figure 5C) and amyA genes (Kd of 245 nM and 77 nM for
unphosphorylated and phosphorylated CovR respectively,
Figure 5D). Similarly, recombinant CcpA bound with high affinity
to putative cre sites from the arcA (Kd of 219 and 18 nM without
and with HPr-Ser46-P respectively) and amyA (Kd of 160 and 32
without and with HPr-Ser46-P respectively) promoters (Figure 5E
and 5F). Together with previous data regarding the binding of
CovR and CcpA-(HPr-Ser46-P) to DNA from virulence factor
encoding genes (Figure 2) [18], these data provide a mechanism
for the extensive overlap observed in the CcpA-CovR transcrip-
tome data.
CcpA and CovR contribute to the alteration in GAS gene
expression observed during growth in human saliva
We have previously demonstrated that GAS markedly alters its
transcriptome during interaction with human saliva compared
with growth in a laboratory medium [30,50]. Given that the
CcpA-(HPr-Ser46-P) complex and CovRS TCS are known to be
part of the process by which GAS responds to changes in the
environment [30,51], we next tested the hypothesis that CcpA and
CovR contribute to how GAS modifies gene expression in
response to interaction with human saliva. We determined the
transcript levels of six genes known to be directly regulated by
CcpA and CovR, four that encode virulence factors and one each
encoding a carbohydrate utilization and amino acid utilization
protein. For the parental wild-type strain MGAS2221, the
transcript level of speB, spyCEP, slo, sagA, arcA, and amyA was
significantly increased during growth in human saliva compared to
THY (Figure 6). In contrast, the transcript level of speB, sagA, and
arcA were not significantly different in strain 2221DccpA between
growth in human saliva and laboratory medium indicating that
Figure 2. Recombinant GAS protein production and phosphor-
ylation assays of recombinant GAS proteins. (A) SDS-PAGE
analysis of recombinant GAS proteins. (B) Recombinant HPr was
incubated with HPrK/P, purified, and analyzed under native conditions
as described in Materials and Methods. Phosphorylation of HPr results
in faster gel migration under these conditions. (C) Recombinant CovR
was phosphorylated using acetyl phosphate as described in Materials
and Methods. Unphosphorylated and phosphorylated CovR were run as
described for HPr. Phosphorylation of CovR results in dimerization and
thus slower migration through the gel under these conditions.
doi:10.1371/journal.ppat.1000817.g002
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in the wild-type strain in human saliva compared with THY
(Figure 6). Although the transcript level of spyCEP and slo were
increased in strain 2221DccpA during growth in human saliva, the
increase in gene transcript level between the two conditions was
significantly less than that observed for strain MGAS2221.
Similarly, the transcript level of each of the six genes tested was
increased in human saliva to a lesser degree in strain 2221DcovR
compared to wild-type (Figure 6). These data indicate that, for the
genes tested, CcpA and CovR participate in the remodeling of
GAS gene expression in response to human saliva.
CcpA and CovR affect GAS virulence and contribute to
the GAS gene expression profile during infection
Thus far in the work, our data had shown significant overlap in
the CcpA and CovR transcriptomes, that CcpA and CovR bind to
DNA from several of the same genes, and the CcpA and CovR are
key to how GAS remodels its gene expression profile during
interaction with human saliva. To study the in vivo relevance of
how CcpA and CovR together contribute to GAS pathogenesis,
we compared the virulence of strain MGAS2221 to mutant strains
2221DccpA, 2221DcovR, and 2221DcovRDccpA using a mouse
myositis model [52]. As expected for a negative virulence-gene
regulator, CovR inactivation significantly decreased mouse
survival compared to wild-type infected animals (Figure 7A,
P,0.01). Conversely, mice infected with strain MGAS2221 had a
significantly increased mortality rate compared to mice infected
with mutant strain 2221DccpA or mutant strain 2221DcovRDccpA
(Figure 7A). We analyzed RNA recovered from GAS in mouse
muscle to correlate the GAS gene expression profile with the
mortality data. The elevated transcript level of virulence factor
encoding genes in strain 2221DcovR compared to strain
MGAS2221 is consistent with the hypervirulent phenotype of
the CovR mutant strain (Figure 7B). However, in contrast to what
was observed during growth in THY, there was no significant
difference in spyCEP, sagA, and slo transcript level between wild-
type and strain 2221DccpA during infection (Figure 7B). In terms of
metabolic genes, there was no significant difference in arcA
transcript level during infection between strain 2221DccpA and its
parental, wild-type strains whereas amyA transcript level was
significantly increased in the CcpA-inactivated strain (Figure 7B).
Finally, compared to strain MGAS2221, speB and hasA transcript
levels were significantly decreased in the CcpA-inactivated strains
in mouse muscle (Figure 7B), providing a potential explanation for
the diminished virulence of the CcpA inactivated strains.
To gain further insight into the molecular mechanisms underlying
G A Sg e n ee x p r e s s i o nd u r i n gi n v a s i v ei n f e c t i o n ,w en e x tc o m p a r e d
select virulence gene transcript levels in strain MGAS2221 during
infection with thoseobserved duringgrowthinTHY.We determined
the relative transcript levels of five virulence factor encoding genes
known to be influenced by CcpA and five genes not known to be
influenced by CcpA (Figure 7C). The transcript level of all of the
CcpA-influenced genes were increased in strain MGAS2221 during
infection compared to growth in THY whereas the transcript level of
only one of the non-CcpA-influenced genes was increased during
infection (Figure 7C). These data suggest that CcpA may be either
repressing gene transcript levels during growth in THY or activating
gene expression during infection. By comparing gene transcript levels
in strain MGAS2221 and 2221DccpA, we found that CcpA repressed
spyCEP, sagA,a n dslo during growth in laboratory medium but not
Figure 3. Recombinant CcpA-(HPr-Ser46-P) binds specifically to DNA from GAS genes encoding virulence factors. Fluorescence
polarization based assay of (A) CcpA-speB, (C) CcpA-nga/slo, and (D) CcpA-spyCEP cre interaction. (B) shows CcpA interaction with DNA from non-
CcpA regulated gene (ftsX, i.e. negative control). Binding assays were done with (red circles) and without (blue circles) 10 mm HPr-Ser46-P.
Representative fluorescence polarization-based binding isotherms are shown of experiments done on four occasions. For (A), (C), and (D) lines
indicate non-linear fit of binding data as described in Materials and Methods. speB, streptococcal pyrogenic exotoxin B; ftsX, cell division protein; nga,
NAD glycohydrolase; slo, streptolysin O; spyCEP, Streptococcus pyogenes cell envelope proteinase.
doi:10.1371/journal.ppat.1000817.g003
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of hasA and speB indicated that CcpA was activating these genes
during infection. Comparison of transcript levels during infection
versus growth in THY for strain MGAS2221 and 2221DcovR
demonstrated that CovR inactivation resulted in relatively similar
effects on GAS gene expression for the two conditions (Figure 7E).
Taken together, we conclude that CcpA and CovR contribute to the
virulence gene expression profiles of GAS during infection but that
the effect of CcpA on GAS gene expression differs significantly
depending on the studied environment.
CcpA inactivation decreases emergence of GAS strains
with spontaneous covRS mutations
The decreased virulence of the CcpA-inactivated strains in the
mouse myositis model suggested there was either a decreased
intensity of the local infectious process for the CcpA-inactivated
strains or that the CcpA-deficient strains had a diminished rate of
bacterial dissemination from the primary infection site. To
distinguish between these two possibilities, we determined the
number of viable GAS CFUs present in mouse limbs (local
infection site) and mouse spleens (disseminated infection site)
48 hrs after infection. We observed no significant difference
among the four strains in the number of viable GAS CFUs present
in the infected limbs at 48 hrs post-inoculation (Figure 7F).
However, the wild-type and 2221DcovR strains were recovered at
significantly higher CFUs from mice spleens compared to the
CcpA inactivated strains (Figure 7F).
Invasive GAS infection can be associated with spontaneous
mutations in covRS [21,26,27,28]. Therefore, one explanation for
the decreased dissemination rate of the CcpA inactivated strains is that
CcpA contributes to the emergence of GAS strains with covRS
mutations. To test this hypothesis, we sequenced the covRS operon of
GAS isolates from the spleens of mice infected with strain MGAS2221
and strain 2221DccpA. covRS mutations were found in 17 of 24 isolates
from mice infected with strain MGAS2221. In contrast,none of the 24
isolates from mice infected with strain 2221DccpA had a covRS
mutation (P,0.01 by Fisher’s exact test). Isolates derived from strain
MGAS2221 had missense mutations in CovR and nonsense
mutations in CovS (see Table 3 for mutation details). These results
indicate that interplay between the CcpA and CovRS systems
contribute to the pathogenesis of invasive GAS infection.
Discussion
It has long been recognized that bacteria react to environmental
changes by altering expression of genes involved in basic metabolic
processes. Indeed, early work on regulation of transcription
demonstrated how activity of the lac operon varied in response
to lactose concentration [53]. Similarly, for many years it has been
recognized that bacterial virulence factor production changes
in response to alterations in the environment [54,55]. However,
the molecular mechanisms underlying the control of bacterial
virulence factor expression in particular environmental conditions,
such as those encountered during human infection, are just
beginning to be fully elucidated [51,56]. Specifically, there has
been limited investigation into how combinations of transcription-
al regulators control gene expression during infection despite the
clear importance of regulatory networks to microbial pathogenesis
[5,57]. The data generated herein demonstrate that the global
metabolic gene regulator CcpA and the virulence factor regulator
CovR act together to control expression of diverse GAS genes
thereby contributing to the critical ability of GAS to remodel its
transcriptome in response to distinct environmental cues.
Table 2. Selected genes/operons co-regulated by CcpA and CovR under laboratory conditions.
Gene category
M5005 spy
number
Gene
name Function of encoded protein(s) 2221DccpA 2221DcovR 2221DcovRDccpA
Virulence factors
0139 nga NAD glycohydrolase 3.6
a 12.1 31.2
0141 slo Pore forming cytoxin 2.7 12.3 25.3
0341 spyCEP IL-8 degrading protease 8.3 17.3 25.5
0562 sagA Secreted cytotoxin 2.7 2.3 8.4
1415 sdaD2 DNase 2.3 2.7 2.2
1540 endoS Immunoglobulin modifying protein 21.3 2.6 26.6
1714 fba Fibronectin-binding protein 3.2 4.1 5.0
1735 speB Secreted cysteine protease 25.2 2.2 25.2
Carbohydrate utilization
0212-8
b Sialic acid production and catabolism 13.7 4.8 37.0
1079-83 Cellobiose transport 8.4 3.1 12.7
1062-7 Cyclodextrin transport and catabolism 7.9 2.4 8.8
1538-43 Sucrose transport and catabolism 13.3 2.3 19.0
1632-8 Lactose transport and catabolism 6.32 2.9 11.3
Amino acid utilization
1271-5 Arginine catabolism 22.0 2.7 29.4
1770-8 Histidine catabolism 5.73 2.3 11.3
aNumbers show mean-fold-change in transcript level between wild-type (strain MGAS2221) and indicated isogenic mutant strain with positive numbers indicating
higher transcript level in isogenic mutant strain compared to wild-type.
bNumbers listed for carbohydrate and amino acid utilization operons indicate mean-fold-change in transcript level for all genes in the indicated operon for isogenic
mutant strain compared to wild-type.
doi:10.1371/journal.ppat.1000817.t002
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generated during this investigation, along with data from previous
studies [16,51,56,58], allows us to generate a model for how CcpA
and CovR participate in the alteration of GAS gene expression
observed when GAS shifts from growth in laboratory medium to
the host (Figure 8). The different environmental carbohydrate
concentrations encountered during infection eventually result in a
change in the ratio of kinase/phosphorylase activity of HPrK/P
thereby altering the concentration of HPr-Ser46-P. The differ-
ences in HPr-Ser46-P levels will affect CcpA cre site interaction (as
demonstrated by the protein binding data in Figures 3 and 5)
thereby altering transcription of GAS virulence factor, carbohy-
drate catabolism, and amino acid catabolism encoding genes
(Figure 8). At the same time, CovS responds to changes in
environmental ion concentrations, such as Mg
2+, and to the
presence of innate immune peptides, by changing the phosphor-
ylation status of CovR [51,56,58]. Phosphorylation/dephosphor-
ylation of CovR alters its interaction with DNA, again changing
the transcription of diverse GAS genes [16]. By having CcpA and
CovR regulate expression of many of the same genes, the
expression of a broad array of key GAS genes can be varied in
response to an array of environmental signals. Appreciation of the
potential complexity of the GAS CcpA-CovRS transcriptional
network was broadened by a recent finding that CovS can either
activate or repress CovR-mediated gene expression depending on
the CovR target gene [16].
Our data demonstrate that the effect of CcpA on gene
expression during host-pathogen interaction was significantly
different from that observed during growth in standard laboratory
medium and was dependent on whether the particular gene was
activated or repressed by CcpA during growth in THY
(Figure 7D). For example, during growth in THY CcpA repressed
the transcript level of the key virulence factor encoding genes sagA,
spyCEP, and slo. However, the transcript levels of these three genes
were not increased in strain 2221DccpA compared to strain
MGAS2221 during infection Our protein-binding data indicate
that binding of CcpA to cre sites in sagA, spyCEP, and slo at
physiologic CcpA concentrations requires the presence of HPr-
Ser46-P (Figure 3) [30,59]. Thus, if GAS is experiencing a low
HPr-Ser46-P state during infection, the absence of the CcpA-
(HPr-Ser46-P) complex will likely release CcpA from cre site
interaction thereby resulting in the increased sagA, spyCEP, and slo
transcript levels observed in strain MGAS2221 in the host
(Figure 7C). In contrast, the transcript levels of genes that were
increased during infection in strain MGAS2221 and are activated
by CcpA, such as speB, remained decreased in the CcpA
inactivated strain compared to wild-type during infection
(Figure 7D). Our findings that CcpA positively influences speB
transcript level and directly binds to the speB regulatory region are
in concert with a recent study examining the role of CcpA in GAS
virulence gene expression (39). A possible explanation for these
data is that recombinant CcpA binds to the speB cre site (Figure 3A)
in the absence of HPr-Ser46-P with a Kd (,100 nM) that is within
the potential physiologic concentration of CcpA as determined in
Bacillus species (20–250 nM) [59]. A previous study of CcpA in B.
subtilis found that CcpA-mediated gene activation did not require
the presence of HPr-Ser46-P [60]. Such a finding is consistent with
our data demonstrating decreased speB transcript level in the
CcpA-inactivated strain under conditions where HPr-Ser46-P
levels are expected to be low or absent, such as growth in human
saliva (Figure 6). Thus, the effect of CcpA on GAS gene expression
in vivo is likely occurring by more than one mechanism. Our
conclusions that CcpA affects gene expression during infection via
multiple mechanisms and that CcpA-inactivation does not alter
sagA transcript levels during host-pathogen interaction are similar
to other recently published data despite the fact that a
subcutaneous, rather than myositis, mouse model was used in
that investigation [39].
Inactivation of CcpA markedly attenuated the virulence of
the parental strain MGAS2221 whereas CovR inactivation
significantly increased virulence (Figure 7A). A possible explana-
tion for these observations can be derived from the expression
microarray data which showed marked increases in the transcript
Figure 4. Identification of significant overlap between the
CcpA and CovR transcriptomes. Differences in gene transcript
levels measured by expression microarray analysis for select GAS
virulence factor encoding genes (A) and genes involved in carbohydrate
and amino acid utilization (B). Data graphed are mean +/2 standard
deviation for quadruplicate samples for strains as indicated in the insert
box. All transcript levels are significantly different compared to strain
MGAS2221 except for the emm gene which is shown for reference
purposes. A significant difference was defined as at least two-fold
difference in median gene transcript level and P,0.05 for the indicated
isogenic mutant strain compared to the parental wild-type strain
MGAS2221. speB, streptococcal pyrogenic exotoxin B; spyCEP, Strepto-
coccus pyogenes cell envelope proteinase; endoS, endoglycosidase S;
sagA, streptolysin S; slo, streptolysin O; emm, M protein; nanH,
acetylneuraminate lyase; amyA, cyclomaltodextrin glucanotransferase;
scrA, sucrose transport enzyme; arcA, arginine deiminase; hutI,
imidazolonepropionase.
doi:10.1371/journal.ppat.1000817.g004
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strain (Figure 4B). Thus, there are likely to be profound meta-
bolic consequences of CcpA inactivation through inefficient
production of proteins involved in carbon source acquisition
and catabolism. Although there were also increases in metabolic
gene transcript levels in the CovR isogenic mutant, the increases
were smaller in comparison to strain 2221DccpA (Figure 4B).
This finding indicates that there may be less metabolic cost of
CovR inactivation compared to CcpA inactivation. Inactivation of
CcpA in the DcovR background markedly decreased GAS
virulence suggesting, in simplistic terms, that the metabolic
consequences of CcpA inactivation outweighed the overexpression
of virulence factors resulting from CovR inactivation. Such
interplay between energy use and virulence factor production
may have contributed to the lack of emergence of spontaneous
mutations in the covRS operon in strain 2221DccpA during murine
soft-tissue infection.
Our discovery that significant overlap exists between the CovRS
and CcpA transcriptional regulatory systems adds to understanding
of the molecular mechanisms used by pathogenic human microbes
to alter protein production in response to environmental changes.
Interestingly, GAS CcpA and CovR binding sites can be proximal,
indicating that the spatial organization of GAS promoters may
allow for protein-protein interaction between the two regulators.
The first description of cooperative DNA binding of a response
regulator and an independent transcriptional regulator in a
prokaryote was recently made in a study of developmental gene
expression in Myxococcus xanthus [61]. We are currently investigating
whether direct interaction between CcpA and CovR contributes to
the ability of GAS to modulate global gene expression during
Figure 5. Recombinant CovR and CcpA bind to DNA from promoter regions of the same genes. (A-D) Representative fluorescence
polarization-based isotherms of unphosphorylated (blue circles) and phosphorylated CovR (red circles, CovR-P) binding to 1 nM of fluorescein-
labeled DNA. Millipolarization units (mP) are plotted against the CovR concentration. (A) Recombinant CovR interaction with DNA from the hasA
promoter (positive control). (B) CovR interaction with DNA from promoter of the non-CovR regulated gene typA (i.e. negative control). For (B) note
linear increase in MP values with increasing CovR concentration indicating low affinity protein-DNA interaction. (C) Recombinant CovR interacting
with DNA from the amino acid utilization gene arcA. (D) CovR interaction with DNA from the carbohydrate utilization gene amyA. CcpA interaction
with arcA cre (E) and amyA cre (F) is shown with (red circles) and without (blue circles) the presence of 10 mm HPr-Ser46-P. For all panels experiments
were done on at least three occasions, and lines indicate fit of binding data as described in Materials and Methods. hasA, hyaluronan synthase; typA,
GTP-binding protein; arcA, arginine deminase; amyA, cyclomaltodextrin glucanotransferase.
doi:10.1371/journal.ppat.1000817.g005
Figure 6. CcpA and CovR contribute to GAS gene expression
during growth in human saliva. GAS strains (red bars = strain
MGAS2221, yellow bars = strain 2221DccpA, and blue bars = strain
2221DcovR) were grown to late exponential phase in standard
laboratory medium (THY) or human saliva and transcript level of
indicated genes were assessed using TaqMan QRT-PCR. Quadruplicate
replicates of each strains were assessed on two separate occasions for a
total of eight replicates. * indicates P,0.05 for difference in mean
transcript level of the indicated gene in human saliva compared with
THY as determined by Student’s t-test assuming unequal variances
using Bonferroni’s adjustment for multiple comparisons. speB, strepto-
coccal pyrogenic exotoxin B; spyCEP, Streptococcus pyogenes cell
envelope proteinase; sagA, streptolysin S; slo, streptolysin O; arcA,
arginine deiminase; amyA, cyclomaltodextrin glucanotransferase.
doi:10.1371/journal.ppat.1000817.g006
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outbred CD-1 mice per GAS strain were infected intramuscularly with 2.5610
7 CFU of indicated strains. Data graphed are survival over time with P
values derived from Kaplan-Meier survival analysis. (B) Transcript levels of select GAS genes were determined in mouse muscle using QRT-PCR. From
left to right bars represent 2221DccpA (red); 2221DcovR (yellow); and 2221DcovRDccpA (blue). (C) Comparison of gene transcripts in strain MGAS2221
during infection compared with late exponential growth phase in THY. Comparison of gene transcripts between (D) strains MGAS2221 and
2221DccpA and (E) strains MGAS2221 and 2221DcovR during infection (blue bars) and during late exponential growth phase in THY (red bars). For (B-
E) data graphed are mean +/2 standard deviation of four biologic replicates analyzed in duplicate. (F) Bacterial density in muscle (lesion site) and
spleen (disseminated infection site). Bars are as for panel A except that green bars represent strain MGAS2221. For all panels, * indicates P,0.05 for
indicated comparison. spyCEP, Streptococcus pyogenes cell envelope proteinase; sagA, streptolysin S; slo, streptolysin O; endoS, endoglycosidase S;
hasA, hyaluronan synthase; speB, streptococcal pyrogenic exotoxin B; emm, M protein; arcA, arginine deiminase; amyA, cyclomaltodextrin
glucanotransferase; speG, streptococcal pyrogenic exotoxin G; mac-1, IgG degrading protease; scpA, streptococcal C5a peptidase; ska, streptokinase.
doi:10.1371/journal.ppat.1000817.g007
Combination of Streptococcal Virulence Regulators
PLoS Pathogens | www.plospathogens.org 10 March 2010 | Volume 6 | Issue 3 | e1000817infection. It has recently been demonstrated that targeting bacterial
virulence factor regulation during infection can decrease infection
severity [3,62]. The data presented herein suggest that the CcpA-
CovRS regulatory network is a potential target for the development
of novel antimicrobials.
Materials and Methods
Ethics statement
Saliva was collected from human volunteers who gave their
written informed consent under an MD Anderson Cancer Center
Table 3. covRS mutations detected in GAS isolates from mice spleens following intramuscular inoculation with strain MGAS2221
and 2221DccpA.
Parental
strain Gene Mutation
Number of
isolates Effect of mutation
MGAS2221 covS Deletion of GAAAA at bp 1209 6 Truncated CovS protein
MGAS2221 covS Deletion of GAAAG at bp 1250 6 Truncated CovS protein
MGAS2221 covR G286A 5 Missense mutation resulting in A96T amino acid change
2221DccpA No mutations identified
doi:10.1371/journal.ppat.1000817.t003
Figure 8. Model for how CcpA and CovR contribute to GAS gene expression profile. Transport of environmental carbohydrates through
the phosphotransferase system mediates HPrK/P kinase/phosphorylase activity thereby affecting the formation of HPr-Ser46-P and thus the
interaction of CcpA with various cre sites. Similarly, CovS responds to environmental stimuli such as low Mg
2+ concentration or the presence of the
human cathelicidin LL-37 [51,69] by altering the phosphorylation of status of CovR thereby modifying CovR-DNA interaction. The binding (or lack
thereof) of CcpA and CovR to GAS DNA results in altered expression of genes encoding virulence factors, carbohydrate catabolism proteins, and
amino acid catabolism proteins critical to the pathogenesis of GAS infection. Proteins that are freely secreted into the extracellular environment (e.g.
SpeB) are shown without a surrounding ellipse. SpeB, streptococcal pyrogenic exotoxin B; SLS, streptolysin S; SpyCEP, Streptococcus pyogenes cell
envelope proteinase; HasA, hyaluronan synthase; AmyA, cyclomaltodextrin glucanotransferase; ScrA, sucrose transport enzyme; ArcA; arginine
deiminase; HutI, imidazolonepropionase.
doi:10.1371/journal.ppat.1000817.g008
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ments were performed according to protocols approved by the
Methodist Hospital Research Institute Institutional Animal Care
and Use Committee.
Bacterial strains and culture media
The strains and plasmids used in this work are presented in Table 1,
and primersused forisogenicmutant strain creation are listed in Table
S5.The serotype M1groupAstreptococcal(GAS)strainsMGAS2221
and MGAS5005 are genetically representative of the serotype
M1 clone responsible for most contemporary (post-1987) human
infections, and both genomes have been sequenced [26]. Strain
MGAS2221 and MGAS5005 are essentially genetically identical
except for a truncation of the CovS protein in strain MGAS5005 [26].
Strain 5005DccpA and comp5005DccpA were described previously
[30]. Strain 2221DccpA and comp2221DccpA were created using non-
polar insertional mutagenesis and plasmid pDCccpA in the same
fashion as that described for CcpA isogenic mutant strains created
from strain MGAS5005 [30]. pDCccpA was created from plasmid
pDC123, which is a low-copy number plasmid capable of replicating
in Gram-positive organisms, by cloning the ccpA gene and promoter
region from strain MGAS5005 into the multi-cloning site of pDC123
[63]. Selection for CcpA inactivation was via spectinomycin at
150 mg/mL and selection for the CcpA-complementing plasmid was
done with chloramphenicol at 4 mg/mL. Strain 2221DcovR was
created as described [16]. Strain 2221DcovRDccpA was created by
placing the spectinomycin resistance cassette in place of the CcpA
gene in the 2221DcovR strain with selection via spectinomycin. Strains
w e r eg r o w ni nan u t r i e n t - r i c hm e d i u m( T o d d - H e w i t tb r o t hw i t h0 . 2 %
yeast extract (THY)) at 37uCw i t h5 %C O 2.
TaqMan transcript level analysis for bacteria grown in
laboratory media
RNA was purified from four biological replicates on two
separate occasions using an RNeasy Mini Kit (Qiagen). TaqMan
real-time QRT-PCR (primers and probes listed Table S5) was
performed with an Applied Biosystems 7500 system using the
previously validated tufA gene as an internal control as described
[64]. For QRT-PCR, a significant difference in transcript level
was defined as having at least a 2-fold difference in the mean
transcript level along with a P value of,0.05 for a two-sample t-
test assuming unequal variance. QRT-PCR data are graphed in a
log2 format to facilitate demonstration of either positive or
negative regulation by CcpA and/or CovR.
Expression microarray analysis
Samples for expression microarray analysis were performed in
quadruplicate. A custom-made Affymetrix GeneChipH that contains
100% of the ORFs of strain MGAS2221 was used for expression
microarray (transcriptome) studies as described [30]. To compare
gene transcript levels between the wild-type and mutant strains, a
two-sample t-test (unequal variance) was applied followed by a false
discovery rate correction (Q,0.05) to account for multiple testing
using Partek Genomics Suite version 6.4. Transcript levels were
considered significantly different when the corrected P value was
,0.05 and the mean difference was at least 2-fold. Principal
component analysis was performed using the Partek Genomics Suite
(Figure S5).
Western immunoblot analysis
GAS strains were grown to indicated growth phases in THY.
SDS-PAGE and immunoblotting were performed using specific
anti-SpeB antibody [65].
Casein hydrolysis assays
Functional SpeB protease activity was determined using casein
hydrolysis as described [44].
Purification and phosphorylation of recombinant GAS
proteins
Recombinant GAS CcpA was purified to homogeneity from
Escherichia coli as previously described (Figure 2A) [30]. Recombi-
nant GAS HPr was obtained using the same cloning strategy as
previously described for recombinant GAS CcpA (Figure 2A) [30].
To obtain functional HPrK/P, the GAS hprK/P gene was cloned
from strain MGAS5005 into plasmid pET21a (Novagen) with
primers designed such that no His tag was attached to the
recombinant HPrK/P protein. An E. coli extract enriched for
recombinant GAS HPrK/P was created by growing the BL21-
HPrK/P cells in LB/ampicillin with 0.5 mM IPTG to an OD600
of 2.0. Cells were centrifuged and washed in 20 mM Tris-HCl
pH 7.6 with 3 mM DTT, recentrifuged, and lysed via sonication
in a buffer containing 0.2 mM Tris-HCl pH 7.6, 0.03 mM DTT,
and 0.5 mM PMSF (a serine protease inhibitor). This lysate is
enriched for HPrK/P (Figure 2A).
Phosphorylation of HPr at serine-46 was accomplished by
incubating 500 ml of recombinant HPr for 20 mins at 37uC with
599 ml of HPrK/P extract in 5 mM ATP, 10 mM fructose-1,6-
bisphosphate, 20 mM Tris-HCl pH 7.5, 1 mM DTT, and 5 mM
MgCl2. To obtain purified HPr-Ser46-P, 100 mL of nickel resin
(Qiagen) was added and the mixture was rotated for 1 hr at room
temperature. The mixture was washed 4 times with 50 mM
NaH2PO4 pH 8.0, 300 mM NaCl, and 20 mM imidazole, and
HPr-Ser-46P was eluted with the same buffer except that the
imidazole concentration was increased to 250 mM. The phos-
phorylation state of HPr was assayed by running the unpho-
sphorylated and phosphorylated proteins on a native glycine gel
(pH 10.4) (Figure 2B). Repeated analyses showed that phosphor-
ylation of HPr was stable for at least one week.
To maintain CovR in its soluble form and to work with
recombinant CovR protein that lacked a tag, we cloned the covR
gene from MGAS5005 into plasmid pTXB1 (New England
BioLabs) which resulted in a fusion protein with an intein tag and
a chitin binding domain. Recombinant CovR was obtained
following the manufacturer’s instructions with release of the intein
tag using DTT (Figure 2A). CovR was phosphorylated as
described [25] with phosphorylation assessed by running unpho-
sphorylated and phosphorylated CovR protein under non-
denaturing conditions as described for HPr-Ser46-P (Figure 2C).
Repeated assays showed a CovR phosphorlyation half-life of about
90 minutes, which is consistent with previous reports [66]. Thus,
all experiments with phosphorylated CovR were performed
immediately following phosphorylation completion. To remove
all phosphorylation reagents, CovR was spun through protein
desalting columns (Pierce) into freshly made DNA binding buffer
(20 mM Tris, pH 7.5, 50 mM NaCl, 2 mM DTT, and 10 mg/mL
of polydI:dC). All protein concentrations were assessed using the
Bradford assay (Bio-Rad).
DNA binding assays
DNA binding activity of CcpA and CovR was studied using a
fluorescence polarization based assay. In brief, fluorescence
polarization is an indirect measurement of the rotation of a
molecule in solution that employs a fluorescently labeled molecule
as a reporter. When two molecules interact, such as a protein
binding to DNA that has been labeled with fluorescein, the
intrinsic rotation of the DNA is slowed which can be observed as
Combination of Streptococcal Virulence Regulators
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known amounts of protein into the binding solution, the
equilibrium dissociation constant (Kd) can be determined [48].
Fluorescence polarization was used as previously described to
determine a series of CcpA-DNA binding constants with and
without HPr-Ser46-P [30]. CovR binding affinities were measured
using fluorescence polarization by titrating solutions of CovR
(unphosphorylated or phosphorylated) into 200 ml of solution
containing labeled DNA (1 nM) in 20 mM Tris, pH 7.5, 50 mM
NaCl, and 2 mM DTT, and 10 mg/mL of polydI:dC. Polarization
was measured at 25uC on a Beacon 2000 fluorescence polarization
instrument (PanVera, Madison, WI). Data were analyzed
assuming a 1:1 binding stoichiometry between functional protein
unit and labeled DNA. Binding parameters were determined via
non-linear regression using the equation Y = ((Bmax N X)/(Kd N
X)) + NS N X where Bmax is the polarization value at maximum
specific binding, Kd is the equilibrium dissociation constant and
NS is the slope of non-specific binding. Goodness of fit (R
2) values
for each of the binding assays was .0.98.
Mouse infection studies
Twenty female outbred CD-1 Swiss mice (Harlan-Sprague-
Dawley) were injected intramuscularly in the right hind limb with
2.5610
7 GAS CFU using an established model of GAS intramus-
cular infection [52]. Comparison of mortality rates was performed
by Kaplan-Meier survival analysis. Differences in mortality rates
were considered significant for a P value of ,0.05 after accounting
for multiple comparisons. For quantitationof inoculation site CFUs,
four mouse limbs per strain treatment group were homogenized in
phosphate buffered saline and plated onto sheep blood agar,
incubated for 24 hrs, and CFU counted. For quantitation of GAS
dissemination,the same protocolwasemployedusingmousespleens
instead of limbs. To compare rates of spontaneous covRS mutations,
GAS colonies from spleens of mice that had been infected with
strain MGAS2221 and 2221DccpA were randomly selected for
sequencing of the entire covRS operon. Six GAS colonies per mouse
(4 mice were inoculated with each strain) were selected for
sequencing for a total of 24 colonies per strain.
Measurement of RNA levels during mouse infection
For transcript level measurement during infection, mice limbs
were immediately placed into RNAlater (Qiagen) and then snap
frozen with liquid nitrogen. GAS RNA was isolated from mouse
limbs as previously described [22]. In brief, the frozen limbs were
subjected to vigorous mechanical lysis with a series of sharp blows
using a three pound drill hammer and FastPrep Lysing Matrix B
(MP Biomedicals). RNA was isolated using a Qiagen RNeasy kit
and treated vigorously with Turbo DNAse (Ambion). cDNAs were
prepared with and without reverse transcriptase to ensure that
TaqMan QRT-PCR signal amplification did not reflect DNA
contamination. Mouse limbs inoculated with PBS were also
included in the analysis to ensure that the observed signal did not
arise from eukaryotic RNA.
Gene IDs [Entrez-Gene numbers]
covR, 3572611; covS, 3572612; ccpA, 3572471; hpr, 3571784;
hprK/P, 3572422; speB, 3571136; nga, 3572762; slo, 3572764;
spyCEP, 3760194; sagA, 3572347; ftsX, 3572932; endoS, 3571346;
hasA, 3571023; typA, 3571645; arcA, 3571626; amyA, 3571845.
Expression microarray data
Expression microarray data have been deposited at the Gene
Expression Omnibus database at National Center for Biotechnol-
ogy Information (http://www.ncbi.nlm.nih.gov/geo) and are
accessible through accession number GSE20212.
Supporting Information
Figure S1 Strain schematic and Southern blot analysis of GAS
isogenic mutant strains used in this study. Isogenic mutant strains
were derived (as indicated by solid lines) from the clinical serotype
M1 isolates MGAS2221 (covRS wild-type) and MGAS5005 (DcovS)
as described in Materials and Methods. Dashed line between
strains MGAS2221 and MGAS5005 indicates that the two strains
are essentially genetically identical except for a truncated CovS
protein in strain MGAS5005 [26,65]. (A) Pictures show colony
morphology of the indicated strains after growth on sheep blood
agar plates overnight. (B, C) Southern blot of genomic DNA from
the indicated GAS strains was digested with (B) KpnI and (C)
HindIII. (B) CcpA inactivation introduces a KpnI restriction
site reducing fragment size from 11 kb to 5.5 kb. (C) CovR
inactivation eliminates a HindIII restriction site increasing
fragment size from 3.6 kb to 4.2 kb.
Found at: doi:10.1371/journal.ppat.1000817.s001 (1.59 MB
DOC)
Figure S2 Growth curves of various GAS strains and indicators
of growth points used for RNA analysis. For (A), (B), and (C) the
indicated strains were grown overnight and then placed into fresh
THY at a 1:100 dilution. OD600 readings were taken hourly until
the end of the experiment. For (A) and (B) arrows indicate points at
which RNA was isolated for transcript level analysis by QRT-
PCR. For (C) arrows indicate points at which RNA was isolated
for expression microarray analysis.
Found at: doi:10.1371/journal.ppat.1000817.s002 (0.31 MB
DOC)
Figure S3 Putative cre sites present in the gene regions of select
GAS virulence factor genes. Shown are putative cre sites for the
early intragenic (speB, spyCEP) and promoter (nga/slo) regions for
the serotype M1 strain MGAS2221 and their relationship to
transcription and translation start sites. The transcription start
site for speB is not shown as there are multiple start sites some
600–1000 bps upstream of the translation start site.
Found at: doi:10.1371/journal.ppat.1000817.s003 (0.20 MB
DOC)
Figure S4 CovR and CcpA do not influence transcript level of
the other regulator. Transcript levels of ccpA (left) and covR (right)
were determined in indicated strains at mid-exponential phase of
growth in THY. For all panels data graphed are mean +/2
standard deviation of four biological replicates done on two
separate occasions (i.e. total of eight samples).
Found at: doi:10.1371/journal.ppat.1000817.s004 (0.06 MB
DOC)
Figure S5 Principal component analysis of the CcpA and CovR
transcriptome analysis. Four biological replicates of each of the
indicated strains were grown to (A) mid-exponential (B) and
stationary growth phases in THY with expression microarray
analysis performed as described in Materials and Methods. Shown
are principal components analyses (PCA) plots, which capture the
variance in a dataset in terms of principal components and
displays the three most significant of these on the X, Y, and Z axes.
Found at: doi:10.1371/journal.ppat.1000817.s005 (0.51 MB
DOC)
Figure S6 Confirmatory QRT-PCR of expression microarray
data and functional SpeB assay. (A to D) QRT-PCR analyzing
transcript level of indicated genes encoding GAS virulence factors
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PLoS Pathogens | www.plospathogens.org 13 March 2010 | Volume 6 | Issue 3 | e1000817found to have significantly different transcript levels in isogenic
mutant strains compared to wild-type by expression microarray
analysis. Indicated strains were grown to labeled growth phases as
detailed in Figure S2B. (E) Casein hydrolysis assays as marker of
SpeB activity. For all panels, data graphed are mean +/2
standard deviation of four biological replicates done on two
separate occasions (i.e. total of 8 samples). * indicates P,0.05
compared to parental strain as determined by ANOVA followed
by Tukey’s post-hoc test. For all panels the relationship of bar
color to GAS strain is indicated in legend.
Found at: doi:10.1371/journal.ppat.1000817.s006 (0.29 MB
DOC)
Table S1 Growth characteristics of various strains in a
laboratory medium (THY)
Found at: doi:10.1371/journal.ppat.1000817.s007 (0.04 MB
DOC)
Table S2 Genes regulated by CcpA in strain MGAS2221 during
growth in standard laboratory medium
Found at: doi:10.1371/journal.ppat.1000817.s008 (0.39 MB
DOC)
Table S3 Genes regulated by CovR in strain MGAS2221 during
growth in standard laboratory medium
Found at: doi:10.1371/journal.ppat.1000817.s009 (0.85 MB
DOC)
Table S4 Genes with altered transcript levels in strain
2221DcovRDccpA vs. wild-type
Found at: doi:10.1371/journal.ppat.1000817.s010 (1.19 MB
DOC)
Table S5 Primers and probes used in this study
Found at: doi:10.1371/journal.ppat.1000817.s011 (0.09 MB
DOC)
Acknowledgments
We thank B. Lei for providing the vector used to overexpress CcpA and
HPr.
Author Contributions
Conceived and designed the experiments: S. Shelburne, R. Olsen, R.
Brennan, J. Musser. Performed the experiments: S. Shelburne, R. Olsen,
B. Suber, P. Sahasrabhojane, P. Sumby. Analyzed the data: S. Shelburne,
R. Olsen, J. Musser. Contributed reagents/materials/analysis tools: S.
Shelburne, R. Olsen, P. Sumby. Wrote the paper: S. Shelburne, R. Olsen,
B. Suber, P. Sahasrabhojane, P. Sumby, R. Brennan, J. Musser.
References
1. Smith H (1958) The use of bacteria grown in vivo for studies on the basis of their
pathogenicity. Annu Rev Microbiol 12: 77–102.
2. Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, et al. (2009)
The Listeria transcriptional landscape from saprophytism to virulence. Nature
459: 950–956.
3. Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ (2005) Small-molecule
inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310:
670–674.
4. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ (2004) Regulation of
virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol
Med Microbiol 40: 1–9.
5. Yoon H, McDermott JE, Porwollik S, McClelland M, Heffron F (2009)
Coordinated regulation of virulence during systemic infection of Salmonella enterica
serovarTyphimurium.PLoSPathog5:e1000306.doi:10.1371/journal.ppat.1000306.
6. Tart AH, Walker MJ, Musser JM (2007) New understanding of the group A
Streptococcus pathogenesis cycle. Trends Microbiol 15: 318–325.
7. Churchward G (2007) The two faces of Janus: virulence gene regulation by
CovR/S in group A streptococci. Mol Microbiol 64: 34–41.
8. Olsen RJ, Shelburne SA, Musser JM (2009) Molecular mechanisms underlying
group A streptococcal pathogenesis. Cell Microbiol 11: 1–12.
9. Hondorp ER, McIver KS (2007) The Mga virulence regulon: infection where
the grass is greener. Mol Microbiol 66: 1056–1065.
10. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, et al. (2002) sigmaB
modulates virulence determinant expression and stress resistance: characteriza-
tion of a functional rsbU strain derived from Staphylococcus aureus 8325-4.
J Bacteriol 184: 5457–5467.
11. Kazmierczak MJ, Wiedmann M, Boor KJ (2005) Alternative sigma factors and
their roles in bacterial virulence. Microbiol Mol Biol Rev 69: 527–543.
12. Kreikemeyer B, McIver KS, Podbielski A (2003) Virulence factor regulation and
regulatory networks in Streptococcus pyogenes and their impact on pathogen-host
interactions. Trends Microbiol 11: 224–232.
13. McIver KS (2009) Stand-alone response regulators controlling global virulence
networks in streptococcus pyogenes. Contrib Microbiol 16: 103–119.
14. Stock AM, Robinson VL, Goudreau PN (2000) Two-component signal
transduction. Annu Rev Biochem 69: 183–215.
15. Gao R, Mack TR, Stock AM (2007) Bacterial response regulators: versatile
regulatory strategies from common domains. Trends Biochem Sci 32: 225–234.
16. Trevino J, Perez N, Ramirez-Pena E, Liu Z, Shelburne SA, 3rd, et al. (2009)
CovS simultaneously activates and inhibits the CovR-mediated repression of
distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect
Immun 77: 3141–3149.
17. Levin JC, Wessels MR (1998) Identification of csrR/csrS, a genetic locus that
regulates hyaluronic acid capsule synthesis in group A Streptococcus.M o l
Microbiol 30: 209–219.
18. Miller AA, Engleberg NC, DiRita VJ (2001) Repression of virulence genes by
phosphorylation-dependent oligomerization of CsrR at target promoters in
Streptococcus pyogenes. Mol Microbiol 40: 976–990.
19. Federle MJ, McIver KS, Scott JR (1999) A response regulator that represses
transcription of several virulence operons in the group A Streptococcus. J Bacteriol
181: 3649–3657.
20. Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, et al.
(2002) Virulence control in group A Streptococcus by a two-component gene
regulatory system: global expression profiling and in vivo infection modeling.
Proc Natl Acad Sci USA 99: 13855–13860.
21. Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ (2001) Spontaneous
mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes
result in enhanced virulence in a murine model of skin and soft tissue infection.
J Infect Dis 183: 1043–1054.
22. Graham MR, Virtaneva K, Porcella SF, Gardner DJ, Long RD, et al. (2006)
Analysis of the transcriptome of group A Streptococcus in mouse soft tissue
infection. Am J Pathol 169: 927–942.
23. Dalton TL, Scott JR (2004) CovS inactivates CovR and is required for growth
under conditions of general stress in Streptococcus pyogenes. J Bacteriol 186:
3928–3937.
24. Gao J, Gusa AA, Scott JR, Churchward G (2005) Binding of the global response
regulator protein CovR to the sag promoter of Streptococcus pyogenes reveals a new
mode of CovR-DNA interaction. J Biol Chem 280: 38948–38956.
25. Federle MJ, Scott JR (2002) Identification of binding sites for the group A
streptococcal global regulator CovR. Mol Microbiol 43: 1161–1172.
26. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM (2006) Genome-
wide analysis of group A streptococci reveals a mutation that modulates global
phenotype and disease specificity. PLoS Pathog 2: e5. doi:10.1371/journal.
ppat.0020005.
27. Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S (2009) Emerging
role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes
infection. J Infect Dis 200: 555–563.
28. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, et al. (2007)
DNase Sda1 provides selection pressure for a switch to invasive group A
streptococcal infection. Nat Med 13: 981–985.
29. Dalton TL, Collins JT, Barnett TC, Scott JR (2006) RscA, a member of the
MDR1 family of transporters, is repressed by CovR and required for growth of
Streptococcus pyogenes under heat stress. J Bacteriol 188: 77–85.
30. Shelburne SA, 3rd, Keith D, Horstmann N, Sumby P, Davenport MT, et al.
(2008) A direct link between carbohydrate utilization and virulence in the major
human pathogen group A Streptococcus. Proc Natl Acad Sci USA 105:
1698–1703.
31. Kinkel TL, McIver KS (2008) CcpA-mediated repression of streptolysin S
expression and virulence in the group A Streptococcus. Infect Immun 76:
3451–3463.
32. Iyer R, Baliga NS, Camilli A (2005) Catabolite control protein A (CcpA)
contributes to virulence and regulation of sugar metabolism in Streptococcus
pneumoniae. J Bacteriol 187: 8340–8349.
33. Seidl K, Bischoff M, Berger-Bachi B (2008) CcpA mediates the catabolite
repression of tst in Staphylococcus aureus. Infect Immun 76: 5093–5099.
34. Abranches J, Nascimento MM, Zeng L, Browngardt CM, Wen ZT, et al. (2008)
CcpA regulates central metabolism and virulence gene expression in Streptococcus
mutans. J Bacteriol 190: 2340–2349.
35. Varga J, Stirewalt VL, Melville SB (2004) The CcpA protein is necessary for
efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens.
J Bacteriol 186: 5221–5229.
Combination of Streptococcal Virulence Regulators
PLoS Pathogens | www.plospathogens.org 14 March 2010 | Volume 6 | Issue 3 | e100081736. Sonenshein AL (2007) Control of key metabolic intersections in Bacillus subtilis.
Nat Rev Microbiol 5: 917–927.
37. Schumacher MA, Allen GS, Diel M, Seidel G, Hillen W, et al. (2004) Structural
basis for allosteric control of the transcription regulator CcpA by the
phosphoprotein HPr-Ser46-P. Cell 118: 731–741.
38. Deutscher J, Francke C, Postma PW (2006) How phosphotransferase system-
related protein phosphorylation regulates carbohydrate metabolism in bacteria.
Microbiol Mol Biol Rev 70: 939–1031.
39. Kietzman CC, Caparon MG (2010) CcpA and LacD.1 affect temporal
regulation of S. pyogenes virulence genes. Infect Immun 78: 241–52.
40. Liang X, Zheng L, Landwehr C, Lunsford D, Holmes D, et al. (2005) Global
regulation of gene expression by ArlRS, a two-component signal transduction
regulatory system of Staphylococcus aureus. J Bacteriol 187: 5486–5492.
41. Seidl K, Muller S, Francois P, Kriebitzsch C, Schrenzel J, et al. (2009) Effect of a
glucose impulse on the CcpA regulon in Staphylococcus aureus. BMC Microbiol 9:
95.
42. Biswas S, Biswas I (2006) Regulation of the glucosyltransferase (gtfBC) operon by
CovR in Streptococcus mutans. J Bacteriol 188: 988–998.
43. Somerville GA, Proctor RA (2009) At the crossroads of bacterial metabolism and
virulence factor synthesis in staphylococci. Microbiol Mol Biol Rev 73: 233–248.
44. Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, et al. (1997)
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly
decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 99:
2574–2580.
45. Hakansson A, Bentley CC, Shakhnovic EA, Wessels MR (2005) Cytolysin-
dependent evasion of lysosomal killing. Proc Natl Acad Sci USA 102:
5192–5197.
46. Sumby P, Zhang S, Whitney AR, Falugi F, Grandi G, et al. (2008) A chemokine-
degrading extracellular protease made by group A Streptococcus alters pathogen-
esis by enhancing evasion of the innate immune response. Infect Immun 76:
978–985.
47. Collin M, Olsen A (2001) EndoS, a novel secreted protein from Streptococcus
pyogenes with endoglycosidase activity on human IgG. EMBO J 20: 3046–3055.
48. Anderson BJ, Larkin C, Guja K, Schildbach JF (2008) Using fluorophore-labeled
oligonucleotides to measure affinities of protein-DNA interactions. Methods
Enzymol 450: 253–272.
49. Bernish B, van de Rijn I (1999) Characterization of a two-component system in
Streptococcus pyogenes which is involved in regulation of hyaluronic acid production.
J Biol Chem 274: 4786–4793.
50. Shelburne SA, 3rd, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, et al. (2005)
Central role of a bacterial two-component gene regulatory system of previously
unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci
USA 102: 16037–16042.
51. Gryllos I, Tran-Winkler HJ, Cheng MF, Chung H, Bolcome R, 3rd, et al. (2008)
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
Proc Natl Acad Sci USA 105: 16755–16760.
52. Turner CE, Kurupati P, Wiles S, Edwards RJ, Sriskandan S (2009) Impact of
immunization against SpyCEP during invasive disease with two streptococcal
species: Streptococcus pyogenes and Streptococcus equi. Vaccine 27: 4923–4929.
53. Jacob F, Monod J (1961) Genetic regulatory mechanisms in the synthesis of
proteins. J Mol Biol 3: 318–356.
54. Callahan LT, 3rd, Richardson SH (1973) Biochemistry of Vibrio cholerae
virulence. 3. Nutritional requirements for toxin production and the effects of
pH on toxin elaboration in chemically defined media. Infect Immun 7: 567–572.
55. Regassa LB, Novick RP, Betley MJ (1992) Glucose and nonmaintained pH
decrease expression of the accessory gene regulator (agr)i nStaphylococcus aureus.
Infect Immun 60: 3381–3388.
56. Gryllos I, Grifantini R, Colaprico A, Jiang S, Deforce E, et al. (2007) Mg(2+)
signaling defines the group A streptococcal CsrRS (CovRS) regulon. Mol
Microbiol 65: 671–683.
57. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS (2006) Regulation of
Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA,a n dsae in vitro
and in experimental infective endocarditis. J Infect Dis 194: 1267–1275.
58. Froehlich BJ, Bates C, Scott JR (2009) Streptococcus pyogenes CovRS mediates
growth in iron starvation and in the presence of the human cationic
antimicrobial peptide LL-37. J Bacteriol 191: 673–677.
59. Miwa Y, Saikawa M, Fujita Y (1994) Possible function and some properties of
the CcpA protein of Bacillus subtilis. Microbiology 140: 2567–2575.
60. Lorca GL, Chung YJ, Barabote RD, Weyler W, Schilling CH, et al. (2005)
Catabolite repression and activation in Bacillus subtilis: dependency on CcpA,
HPr, and HprK. J Bacteriol 187: 7826–7839.
61. Mittal S, Kroos L (2009) A combination of unusual transcription factors binds
cooperatively to control Myxococcus xanthus developmental gene expression. Proc
Natl Acad Sci USA 106: 1965–1970.
62. Rasko DA, Moreira CG, Li de R, Reading NC, Ritchie JM, et al. (2008)
Targeting QseC signaling and virulence for antibiotic development. Science 321:
1078–1080.
63. Chaffin DO, Rubens CE (1998) Blue/white screening of recombinant plasmids
in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ)
expression. Gene 219: 91–99.
64. Virtaneva K, Porcella SF, Graham MR, Ireland RM, Johnson CA, et al. (2005)
Longitudinal analysis of the group A Streptococcus transcriptome in experimental
pharyngitis in cynomolgus macaques. Proc Natl Acad Sci USA 102: 9014–9019.
65. Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, et al. (1993) A
conserved Streptococcus pyogenes extracellular cysteine protease cleaves human
fibronectin and degrades vitronectin. Microb Pathog 15: 327–346.
66. Gusa AA, Gao J, Stringer V, Churchward G, Scott JR (2006) Phosphorylation of
the group A streptococcal CovR response regulator causes dimerization and
promoter-specific recruitment by RNA polymerase. J Bacteriol 188: 4620–4626.
67. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, et al. (2005)
Evolutionary origin and emergence of a highly successful clone of serotype M1
group A Streptococcus involved multiple horizontal gene transfer events. J Infect
Dis 192: 771–782.
68. Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, et al. (2000) Nonpolar
inactivation of the hypervariable streptococcal inhibitor of complement gene (sic)
in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal
colonization. Infect Immun 68: 535–542.
69. Gryllos I, Levin JC, Wessels MR (2003) The CsrR/CsrS two-component system
of group A Streptococcus responds to environmental Mg2+. Proc Natl Acad Sci
USA 100: 4227–4232.
Combination of Streptococcal Virulence Regulators
PLoS Pathogens | www.plospathogens.org 15 March 2010 | Volume 6 | Issue 3 | e1000817